Cvs Pharmacy #16472 Durable Medical Equipment & Medical Supplies Location: 860 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 452-6308 |
Walgreens #7727 Durable Medical Equipment & Medical Supplies Location: 750 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 452-4076 |
Hy-vee Pharmacy (1896) Durable Medical Equipment & Medical Supplies Location: 1475 W Service Dr, Winona, Minnesota 55987 Phone: (507) 452-5254 |
Wal Mart Pharmacy 10-5397 Durable Medical Equipment & Medical Supplies Location: 955 Frontenac Dr, Winona, Minnesota 55987 Phone: (507) 452-0615 |
Winona Health Services Clinic Pharm Specialty Pharmacy Location: 859 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 457-7688 |
Winona Home Medical Durable Medical Equipment & Medical Supplies Location: 930 Parks Ave, Winona, Minnesota 55987 Phone: (507) 457-7703 |
Winona Health Services Non-Pharmacy Dispensing Site Location: 855 Mankato Ave, Winona, Minnesota 55987 Phone: (507) 454-3650 |
Gundersen Lutheran Medical Center Pharmacy Location: 1122 W Highway 61, Winona, Minnesota 55987 Phone: (608) 782-7300 |
Gundersen Winona Eye Clinic Medicare Supplier Location: 106 E 2nd St, Winona, Minnesota 55987 Phone: (507) 454-4640 |
Robeson Family Vision Center Durable Medical Equipment & Medical Supplies Location: 1400 Homer Rd, Winona, Minnesota 55987 Phone: (507) 454-4092 |
News Archive
A survey from the American Psychiatric Association has found that workers' fears about losing their status at work and about confidentiality are the reasons American workers hesitate to seek treatment for mental health issues, HealthDay/BusinessWeek reports.
University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilized gold with biodegradable and biocompatible systems that have been obtained with 3D-printng techniques.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
Malignant melanoma is a highly aggressive and notoriously chemoresistant form of cancer. In this paper, Ohanna et al. reveal that anti-melanoma drugs may, paradoxically, induce a senescence-associated secretory profile ("secretome") that can ultimately promote metastasis and contribute to melanoma relapse.
› Verified 6 days ago